CBD+CBN Sleep Formula with Melatonin by Bernard Jensen's — Ingredients, Evidence & Safety

Product Label

📄 Open Full PDF View on NIH DSLD →

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Safety Alerts

ℹ️ Contains proprietary blend — exact ingredient amounts not disclosed

Label Data

1 Capsule(s) Serving Size

30 Servings

Other Combinations Product Type

33% Evidence Coverage

Supplement Facts — Evidence Check

Magnesium

35 mg (8% DV)

📊 Market median: 4002.0mg (1 products) 📚 20 studies (Tier A: 0, B: 2)

This product: 35mg

Proprietary Blend

650 mg

Gamma-Aminobutyric Acid

50 mg

Melatonin

6 mg

📊 Market median: 3.0mg (984 products) 📚 236 studies (Tier A: 2, B: 109)

This product: 6mg UL 10mg

Cannabidiol

12 mg

Cannabinol

6 mg

Other Ingredients

Tapioca

Label Claims — Verification

❓ All Other

❓ Structure/Function

All Other (100% of products) Structure/Function (86% of products) Nutrient (7% of products)

Target Groups

Adult (18 - 50 Years) Women (not pregnant or lactating)

Product Information

📋 Directions for Use

Suggested Use: Take up to 2 capsules before bedtime.

⚠️ Warnings & Precautions

Caution: May cause drowsiness. Do not operate a vehicle or machinery while taking this product. If any adverse reactions occur, discontinue and consult a physician. This product contains less than 0.3% total THC and D9-THC.

Not intended for use by anyone under age 18.

Do not use if you are pregnant or nursing. If you are taking any medication, consult a physician taking before taking this product.

Warning: This product may contain a chemical known to the State of California to cause cancer, birth defects or other reproductive harm. For more information, go to www.P65warnings.ca.gov.

Keep out of reach of children.

🧪 Formulation Notes

Made in USA

Additional Information

Bernard Jensen's Quality products since 1963

Store in a cool, dry place.

Please recycle

Product Details

UPC / SKU 7 26434 55200 6

DSLD Entry Date 2024-08-22

Product Type Other Combinations

Form Capsule

Brand Bernard Jensen's

DSLD ID 318452

Data Updated 2026-04-11

Research Evidence

291 Research Sources

55 Avg Quality Score

129 Meta Analysis

93 Systematic Review

51 Rct

11 Clinical Trial

2 Other

2 Regulatory Source

1 Openfda Safety

A Interventions for preventing delirium in hospitalised non-ICU patients

Meta Analysis The Cochrane database of systematic reviews 2016

PubMed DOI

A Melatonin for preoperative and postoperative anxiety in adults

Meta Analysis The Cochrane database of systematic reviews 2020

PubMed DOI Cochrane

A Effect of melatonin on quality of life and symptoms in patients with cancer: a systematic review and meta-analysis of randomised controlled trials

Meta Analysis BMJ open 2022

PubMed DOI

B Pharmacological interventions for prevention of weight gain in people with schizophrenia

Meta Analysis The Cochrane database of systematic reviews 2022

PubMed DOI

B Melatonin for pre- and postoperative anxiety in adults

Meta Analysis The Cochrane database of systematic reviews 2015

PubMed DOI Cochrane

B Prevention of depression in adults with long-term physical conditions

Meta Analysis The Cochrane database of systematic reviews 2021

PubMed DOI

B Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: a systematic review and network meta-analysis

Systematic Review Lancet (London, England) 2022

PubMed DOI

B Does melatonin administration reduce the incidence of postoperative delirium in adults? Systematic review and meta-analysis

Meta Analysis BMJ open 2023

PubMed DOI

B Second-generation antidepressants for preventing seasonal affective disorder in adults

Meta Analysis The Cochrane database of systematic reviews 2015

PubMed DOI

B Interventions for preventing type 2 diabetes in adults with mental disorders in low- and middle-income countries

Meta Analysis The Cochrane database of systematic reviews 2021

PubMed DOI

View all evidence for Melatonin →